永顺生物
(920729)
| 流通市值：5.43亿 | | | 总市值：19.16亿 |
| 流通股本：7750.70万 | | | 总股本：2.73亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 87,485,096.54 | 47,452,322.97 | 238,174,536.39 | 179,973,670.63 |
| 营业总成本 | 84,702,179.66 | 43,338,273.37 | 206,942,003.57 | 156,149,380.07 |
| 其他经营收益 | | | | |
| 营业利润 | 6,562,085.49 | 5,378,870.13 | 46,290,370.35 | 34,057,129.58 |
| 利润总额 | 6,741,928.49 | 5,412,144.78 | 46,195,892.78 | 33,998,945.33 |
| 净利润 | 6,414,601.68 | 5,083,098.81 | 41,257,977.62 | 30,283,823.27 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 6,414,601.68 | 5,083,098.81 | 41,257,977.62 | 30,283,823.27 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 400,341,350.67 | 269,250,866.9 | 293,154,987.07 | 612,154,369.03 |
| 非流动资产: | | | | |
| 非流动资产合计 | 349,264,924.96 | 525,038,311.44 | 500,700,529.12 | 178,901,183.26 |
| 资产总计 | 749,606,275.63 | 794,289,178.34 | 793,855,516.19 | 791,055,552.29 |
| 流动负债: | | | | |
| 流动负债合计 | 88,611,004.72 | 105,878,134.82 | 111,316,290.98 | 120,625,556.4 |
| 非流动负债: | | | | |
| 非流动负债合计 | 6,636,966.9 | 6,976,141.51 | 6,875,849.61 | 7,683,849.58 |
| 负债合计 | 95,247,971.62 | 112,854,276.33 | 118,192,140.59 | 128,309,405.98 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 654,358,304.01 | 681,434,902.01 | 675,663,375.6 | 662,746,146.31 |
| 股东权益合计 | 654,358,304.01 | 681,434,902.01 | 675,663,375.6 | 662,746,146.31 |
| 负债和股东权益合计 | 749,606,275.63 | 794,289,178.34 | 793,855,516.19 | 791,055,552.29 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 98,572,863.08 | 50,727,467.76 | 277,217,012.02 | 203,404,467.92 |
| 经营活动现金流出小计 | 95,664,996.87 | 50,437,877.18 | 177,184,316.61 | 128,742,828.94 |
| 经营活动产生的现金流量净额 | 2,907,866.21 | 289,590.58 | 100,032,695.41 | 74,661,638.98 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 392,402,352.94 | 186,166,395.15 | 361,110,466.91 | 311,473,424.09 |
| 投资活动现金流出小计 | 339,680,102 | 162,238,200 | 457,540,495.9 | 384,789,205.9 |
| 投资活动产生的现金流量净额 | 52,722,250.94 | 23,928,195.15 | -96,430,028.99 | -73,315,781.81 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 495,984.32 | 495,984.32 | 15,514,413.62 | 15,514,413.62 |
| 筹资活动现金流出小计 | 35,850,890.36 | 157,695.18 | 36,166,424.8 | 36,009,534.86 |
| 筹资活动产生的现金流量净额 | -35,354,906.04 | 338,289.14 | -20,652,011.18 | -20,495,121.24 |
| 汇率变动对现金及现金等价物的影响 | -779,574.04 | -324,759.84 | -153,330.43 | 31,809.41 |
| 现金及现金等价物净增加额 | 19,495,637.07 | 24,231,315.03 | -17,202,675.19 | -19,117,454.66 |
| 期末现金及现金等价物余额 | 38,733,536.06 | 43,469,214.02 | 19,237,898.99 | 17,323,119.52 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 19,495,637.07 | - | -17,202,675.19 | - |